weight watchers and glp 1 🎧 Can @weightwatchers shape up in the GLP-1 era?, At one point in time not too long ago, was the legacy name in weight loss treatment., Usurped by powerful weight loss drugs WeightWatchers' stock reverses gains despite

Although these trials focus on obesity management, the population recruited was either at risk of weight-related complications or at high risk for CVD

Current consensus is that GLP-1 treatment benefits outweigh the risk of EWDR: the drugs reduce the risk of further microvascular damage from poor glycemic control and reduce the chance of death from cardiovascular disease, while the impact on DR is short-lived and can be treated

This added mechanism improves insulin sensitivity and insulin secretory responses

Peak Wellness is the parent brand of this publication and is scored on the same methodology as every other provider

-1.3% and -1.6% with exenatide once-weekly)